| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 616 | 2017 |
| Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies R Massie, ML Mauermann, NP Staff, KK Amrami, JN Mandrekar, PJ Dyck, ... Brain 135 (10), 3074-3088, 2012 | 134 | 2012 |
| Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia D Pellerin, MC Danzi, C Wilke, M Renaud, S Fazal, MJ Dicaire, CK Scriba, ... New England Journal of Medicine 388 (2), 128-141, 2023 | 116 | 2023 |
| Polymerase gamma 1 mutations: clinical correlations M Milone, R Massie The neurologist 16 (2), 84-91, 2010 | 111 | 2010 |
| Canadian Cardiovascular Society/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis NM Fine, MK Davis, K Anderson, DH Delgado, G Giraldeau, A Kitchlu, ... Canadian Journal of Cardiology 36 (3), 322-334, 2020 | 102 | 2020 |
| Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy JJ Figueroa, PJB Dyck, RS Laughlin, JA Mercado, R Massie, P Sandroni, ... Neurology 78 (10), 702-708, 2012 | 100 | 2012 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 86 | 2023 |
| Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial V Meininger, A Genge, LH van den Berg, W Robberecht, A Ludolph, ... The Lancet Neurology 16 (3), 208-216, 2017 | 80 | 2017 |
| Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients A Meyer, Y Troyanov, J Drouin, G Oligny-Longpré, O Landon-Cardinal, ... Arthritis Research & Therapy 22, 1-10, 2020 | 67 | 2020 |
| Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial R Hughes, MC Dalakas, I Merkies, N Latov, JM Léger, E Nobile-Orazio, ... The Lancet Neurology 17 (8), 689-698, 2018 | 63 | 2018 |
| Autoimmune peripheral neuropathies PR Bourque, JW Chardon, R Massie Clinica Chimica Acta 449, 37-42, 2015 | 51 | 2015 |
| Exercise intolerance due to cytochrome b mutation R Massie, LJC Wong, M Milone Muscle & nerve 42 (1), 136-140, 2010 | 29 | 2010 |
| Provincial differences in the diagnosis and care of amyotrophic lateral sclerosis VL Hodgkinson, J Lounsberry, A Mirian, A Genge, T Benstead, ... Canadian Journal of Neurological Sciences 45 (6), 652-659, 2018 | 23 | 2018 |
| Autoantibody profiles delineate distinct subsets of scleromyositis V Leclair, J D’Aoust, G Gyger, O Landon-Cardinal, A Meyer, E O'Ferrall, ... Rheumatology 61 (3), 1148-1157, 2022 | 22 | 2022 |
| The Canadian neuromuscular disease registry 2010–2019: a decade of facilitating clinical research Througha Nationwide, Pan-NeuromuscularDisease Registry V Hodgkinson, J Lounsberry, S M’Dahoma, A Russell, G Jewett, ... Journal of neuromuscular diseases 8 (1), 53-61, 2021 | 19 | 2021 |
| MTP deficiency caused by HADHB mutations: Pathophysiology and clinical manifestations R Dagher, R Massie, BJ Gentil Molecular Genetics and Metabolism 133 (1), 1-7, 2021 | 17 | 2021 |
| Canadian guidelines for hereditary transthyretin amyloidosis polyneuropathy management M Alcantara, MM Mezei, SK Baker, A Breiner, P Dhawan, A Fiander, ... Canadian Journal of Neurological Sciences 49 (1), 7-18, 2022 | 16 | 2022 |
| Temporal evolution of nerve conduction study abnormalities in anti‐myelin‐associated glycoprotein neuropathy PR Bourque, J Masson‐Roy, J Warman‐Chardon, R Massie, M Melanson, ... Muscle & nerve 63 (3), 401-404, 2021 | 13 | 2021 |
| A national spinal muscular atrophy registry for real-world evidence VL Hodgkinson, M Oskoui, J Lounsberry, S M’Dahoma, E Butler, ... Canadian Journal of Neurological Sciences 47 (6), 810-815, 2020 | 12 | 2020 |
| Mitochondrial myopathy due to novel missense mutation in the cytochrome c oxidase 1 gene R Massie, J Wang, LC Chen, VW Zhang, MP Collins, LJC Wong, M Milone Journal of the neurological sciences 319 (1-2), 158-163, 2012 | 12 | 2012 |
